Novartis plans spinoff of Alcon, $5 billion share buy-back June 29, 2018 Joerg Reinhardt said "The review concluded that a spinoff would be in the best interests of Novartis shareholders." from Moneycontrol Business News https://ift.tt/2KxxJQO Share Get link Facebook X Pinterest Email Other Apps Labels Business Moneycontrol Business News Share Get link Facebook X Pinterest Email Other Apps Comments
Joerg Reinhardt said "The review concluded that a spinoff would be in the best interests of Novartis shareholders."
Comments
Post a Comment